Abstract
Network meta-analysis combines aggregate data (AgD) from multiple randomized controlled trials, assuming that any effect modifiers are balanced across populations. Individual participant data (IPD) meta-regression is the ‘gold standard’ method to relax this assumption, however IPD are frequently only available in a subset of studies. Multilevel network meta-regression (ML-NMR) extends IPD meta-regression to incorporate AgD studies whilst avoiding aggregation bias. However, implementation of this method so far has required the aggregate-level likelihood to have a known closed form, which has prevented application to time-to-event outcomes. We extend ML-NMR to individual-level likelihoods of any form, by integrating the individual-level likelihood function over the AgD covariate distributions to obtain the respective marginal likelihood contributions. We illustrate with two examples of time-to-event outcomes: modelling progression-free survival in newly diagnosed multiple myeloma using flexible baseline hazards with cubic M-splines, and a simulated comparison showing the performance of ML-NMR with little loss of precision from a full IPD analysis. Extending ML-NMR to general likelihoods, including for survival outcomes, greatly increases the applicability of the method. R and Stan code is provided, and the methods are implemented in the multinma R package.
| Original language | English |
|---|---|
| Article number | qnaf169 |
| Number of pages | 20 |
| Journal | Journal of the Royal Statistical Society. Series A: Statistics in Society |
| Early online date | 29 Oct 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 29 Oct 2025 |
Bibliographical note
Publisher copyright:© The Royal Statistical Society 2025.
Fingerprint
Dive into the research topics of 'Multilevel network meta-regression for general likelihoods: synthesis of individual and aggregate data with applications to survival analysis'. Together they form a unique fingerprint.-
Effective population adjustment in evidence synthesis of randomised controlled trials for health technology assessment
Phillippo, D. M. (Principal Investigator)
1/04/22 → 31/03/27
Project: Research
-
8071 MRC via York - HOD1: Inferring relative treatment effects from combined randomised and oberservational data
Welton, N. J. (Principal Investigator)
1/01/19 → 30/06/22
Project: Research
-
No Pfizer: Calibration of multiple treatment comparisons using individual patient data
Welton, N. J. (Principal Investigator)
1/03/17 → 29/02/20
Project: Research
Student theses
-
Calibration of Treatment Effects in Network Meta-Analysis using Individual Patient Data
Phillippo, D. M. (Author), Welton, N. (Supervisor) & Dias, S. (Supervisor), 28 Nov 2019Student thesis: Doctoral Thesis › Doctor of Philosophy (PhD)
File
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver